MicroRNA-140-5p inhibits the progression of colorectal cancer by targeting VEGFA

Cellular Physiology and Biochemistry

Volumn 37, Issue 3, 2015, Pages 1123-1133

  Zhang, Wenbo ^a   Zou, Chen ^a   Pan, Lei ^a   Xu, Ying ^a   Qi, Weidong ^a   Ma, Gui ^a   Hou, Yongzhong ^b   Jiang, Pengcheng ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Colorectal cancer; MiR 140 5p; VEGFA

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 140 5P; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN A; 3' UNTRANSLATED REGION; MIRN140 MICRORNA, HUMAN; VEGFA PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; ATTENUATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL ASSAY; CELL COUNTING; CELL COUNTING KIT 8 ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; LUCIFERASE ASSAY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; 3' UNTRANSLATED REGION; CELL MOTION; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MALE; MICRORNAS; PROGNOSIS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84942255882     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430237     Document Type: Article

References (34)

1. Siegel R, Desantis C, Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64:104-117.
2. Hegde SR, Sun W, Lynch JP: Systemic and targeted therapy for advanced colon cancer. Expert Rev Gastroenterol Hepatol 2008; 2:135-149.
3. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
4. Forman JJ, Legesse-Miller A, Coller HA: A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 2008; 105:14879-14884.
5. Ventura A, Jacks T: MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136:586-591.
6. Mendell JT: MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005; 4:1179-1184.
7. Xuan Y, Yang H, Zhao L., Lau WB, Lau B, Ren N, Hu Y., Yi T, Zhao X, Zhou S., Wei Y: MicroRNAs in colorectal cancer: small molecules with big functions. Cancer Lett 2015; 360:89-105.
8. Dong Y, Yu J, Ng SS: MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Manag Res 2014; 6:405-422.
9. Yang J, Qin S, Yi C., Ma G, Zhu H, Zhou W., Xiong Y, Zhu X, Wang Y., He L, Guo X: MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Lett 2011; 585:2992-2997.
10. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F., Casalini P, Taccioli C, Volinia S., Liu CG, Alder H, Calin GA, Menard S, Croce CM: MicroRNA signatures in human ovarian cancer. Cancer Res 2007; 67:8699-8707.
11. Yuan Y, Shen Y, Xue L., Fan H: miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor. PLoS One 2013; 8:e73604.
12. Li W, He F: Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer. Biochem Biophys Res Commun 2014; 450:844-850.
13. Song B, Wang Y, Xi Y., Kudo K, Bruheim S, Botchkina G.I., Gavin E., Wan Y, Formentini A, Kornmann M., Fodstad O, Ju J: Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009; 28:4065-4074.
14. Zhai H, Fesler A, Ba Y., Wu S, Ju J: Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy. Oncotarget. Oncotarget 2015; 6:19735-19746.
15. Yang H, Fang F, Chang R., Yang L: MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology 2013; 58:205-217.
16. Zhang Y, Eades G, Yao Y., Li Q, Zhou Q: Estrogen receptor alpha signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem 2012; 287:41514-41522.
17. Li W, Jiang G, Zhou J., Wang H, Gong Z, Zhang Z., Min K, Zhu H, Tan Y: Down-regulation of miR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer. Cell Physiol Biochem 2014; 34:1466-1476.
18. Sand M, Skrygan M, Sand D., Georgas D, Hahn SA, Gambichler T, Altmeyer P., Bechara FG: Expression of microRNAs in basal cell carcinoma. Br J Dermatol 2012; 167:847-855.
19. Nicolas FE, Pais H, Schwach F., Lindow M, Kauppinen S, Moulton V., Dalmay T: mRNA expression profiling reveals conserved and non-conserved miR-140 targets. RNA Biol 2011; 8:607-615.
20. Pais H, Nicolas FE, Soond S.M., Swingler TE, Clark IM, Chantry A, Moulton V., Dalmay T: Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level. RNA 2010; 16:489-494.
21. Miyaki S, Sato T, Inoue A., Otsuki S, Ito Y, Yokoyama S., Kato Y, Takemoto F, Nakasa T., Yamashita S, Takada S, Lotz M.K., Ueno-Kudo H, Asahara H: MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010; 24:1173-1185.
22. Malzkorn B, Wolter M, Liesenberg F., Grzendowski M, Stuhler K, Meyer H.E., Reifenberger G: Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 2010; 20:539-550.
23. Tardif G, Hum D, Pelletier J.P., Duval N., Martel-Pelletier J: Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2009; 10:148.
24. Shersher DD, Vercillo MS, Fhied C, Basu S., Rouhi O, Mahon B, Coon J.S., Warren WH, Faber LP, Hong E, Bonomi P., Liptay MJ, Borgia JA: Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer. Ann Thorac Surg 2011; 92:1805-1811; discussion 1811.
25. Ahn BY, Elwi AN, Lee B, Trinh D.L., Klimowicz AC, Yau A, Chan JA, Magliocco A, Kim SW: Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancer. Cancer Res 2010; 70:3013-3019.
26. Mosakhani N, Lahti L, Borze I., Karjalainen-Lindsberg ML, Sundstrom J, Ristamaki R., Osterlund P, Knuutila S, Sarhadi VK: MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF. Cancer Genet 2012; 205:545-551.
27. Ferroni P, Spila A, Martini F., D'Alessandro R, Mariotti S, Del Monte G, Graziano P, Buonomo O., Guadagni F, Roselli M: Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer. Oncology 2005; 69:145-153.
28. Des Guetz G., Uzzan B, Nicolas P., Cucherat M, Morere JF, Benamouzig R, Breau J.L., Perret GY: Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 2006; 94:1823-1832.
29. Grothey A, Galanis E: Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 2009; 6:507-518.
30. Thornton AD, Ravn P, Winslet M., Chester K: Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer. Br J Surg 2006; 93:1456-1463.
31. Zhu X, Er K, Mao C., Yan Q, Xu H, Zhang Y., Zhu J, Cui F, Zhao W., Shi H: miR-203 suppresses tumor growth and angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol Biochem 2013; 32:64-73.
32. Wang W, Ren F, Wu Q., Jiang D, Li H, Shi H: MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer. Oncol Rep 2014; 32:2127-2133.
33. Chai ZT, Kong J, Zhu X.D., Zhang YY, Lu L, Zhou JM, Wang L.R., Zhang KZ, Zhang QB, Ao JY, Wang M, Wu W.Z., Wang L., Tang ZY, Sun HC: MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2alpha/Akt/HIF-1alpha pathway in hepatocellular carcinoma. PLoS One 2013; 8:e77957.
34. Hsu CY, Hsieh TH, Tsai C.F., Tsai HP, Chen HS, Chang Y, Chuang H.Y., Lee JN, Hsu YL, Tsai EM: miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. J Pathol 2014; 232:330-343.